Share This Author
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
In this 4th edition of the Maastricht consensus report aspects related to the clinical role of H pylori were looked at again in 2010, with recommendations to guide doctors involved in the management of this infection associated with various clinical conditions.
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
This fifth edition of the Maastricht Consensus Report describes how experts from 24 countries examined new data related to H. pylori infection in the various clinical scenarios and provided recommendations on the basis of the best available evidence and relevance.
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
H pylori eradication is less effective than proton pump inhibitor (PPI) treatment in preventing ulcer recurrence in long term NSAID users and a test and treat strategy using a non-invasive test is recommended in adult patients with persistent dyspepsia under the age of 45.
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis.
Large amounts of variation among regions are observed among regions-more than half the world's population is infected, which can be used in development of customized strategies for the global eradication.
Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report
- P. Malfertheiner, F. Mégraud, G. Tytgat
- MedicineAlimentary pharmacology & therapeutics
- 1 February 2002
The European Helicobacter Pylori Study Group organized a meeting of specialists and experts from around the world, representatives from National Gastroenterology Societies and general practitioners from Europe to establish updated guidelines on the current management of Helicobacteria pylori infection.
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer
- J. Weigt, P. Malfertheiner
- Biology, MedicineExpert review of gastroenterology & hepatology
- 1 August 2010
Cisplatin plus gemcitabine, compared with gem citabine alone, was associated with a significant survival advantage without an increase in substantial toxicity.
European consensus conference on faecal microbiota transplantation in clinical practice
This consensus report strongly recommends the implementation of FMT centres for the treatment of C. difficile infection as well as traces the guidelines of technicality, regulatory, administrative and laboratory requirements.
Kyoto global consensus report on Helicobacter pylori gastritis
A global consensus for gastritis was developed for the first time, which will be the basis for an international classification system and for further research on the subject.
Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline.
Therapeutic vaccination is probably the only strategy that would make a decisive difference in the prevalence and incidence of Hp throughout the world, and would be a test-and-treat strategy for those who are at risk for peptic ulcer disease or gastric cancer, as well as for those with troublesome dyspepsia.
Hepatocellular Carcinoma – Epidemiological Trends and Risk Factors
Information is given on epidemiological trends and risk factors and their mechanisms involved in the hepatocarcinogenesis that will help improve current concepts for prevention, screening and treatment of this disease.